• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD MEDICAL (BD WEST) MEDICAL SURGICAL BD POSIFLUSH¿ HEPARIN LOCK FLUSH SYRINGES; HEPARIN FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD MEDICAL (BD WEST) MEDICAL SURGICAL BD POSIFLUSH¿ HEPARIN LOCK FLUSH SYRINGES; HEPARIN FLUSH Back to Search Results
Catalog Number 306424
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Respiratory Distress (2045); Reaction (2414); Sweating (2444)
Event Date 05/01/2018
Event Type  Injury  
Manufacturer Narrative
This mdr is intended to report 1 of the 2 events described in the event.Another mdr will be filed for the 2nd incident.(2nd event submitted with mdr report# 1911916-2018-00230) the customer's address is unknown.Unknown, (b)(6), 0000 usa has been used as a default.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation and/or device history review, a supplemental report will be filed.
 
Event Description
¿it was reported that on two occasions ((b)(6)), after 30 minutes of pushing iv saline, patient experienced a severe reaction (coughing, couldn't breathe, cold sweats).Patient also used heparin flush but thinks the issue was from the saline more so than the heparin.Patient went to the er on both occasions and was told that nothing was able to be determined.Er checked the patient's lungs, checked for embolism, etc.¿ there was no additional specific information on the medical interventions received.
 
Manufacturer Narrative
(b)(6).
 
Manufacturer Narrative
Dhr/bhr review : there was no documentation of issues for the complaint of batch 716087n during this production run.There was no documentation of issues for the complaint of batch 723060n during this production run.Investigation comments: all our inspections and testing performed while manufacturing this batch were accepted.No rejections were documented.Controls in place, at the manufacturing site: bioburden tested on a weekly basis.An overkill sterilization process is used.Environmental testing within the filling area is done on a biweekly basis.The sterilization process is challenged and re-qualified annually.The solution is filtered twice before it is filled in syringes (note: once when transferring to the hold tank and again at the fill machine).Endotoxin testing is performed on each batch.Fill room operators are trained and qualified on gowning for the fill room environment on an annual basis.Weekly bioburden testing on the components used to assemble the syringes.Continuous online monitoring of the wfi water quality (note: this is for toc and conductivity, not microbial - weekly bioburden and endotoxin testing of the usp purified water and wfi systems.Weekly endotoxin testing of the pure steam system.Each sterilizer is thoroughly validated before used for posiflush sterilization.Update.Jun05, 2018.Five (5) samples were received.They are in their sealed packaging flow wrap.They all have the plunger rod-rubber stopper, tip cap, and saline solution.The barrel label shows the lot# 723060n.This is a different batch # than the one reported.Samples will be sent to a lab for testing.Note: these five(5) samples are the same for complaint (b)(4) and (b)(4) product within specification? yes? no? root cause could not be determined.There were no qns issued during the production of this batch listed in the complaint.All inspections and testing were accepted during the production of this batch.Update.Jun05, 2018.The five (5) samples received will be sent for lab testing.This report will be updated when the lab results are available.Capa not required for this event.Investigation conclusion: root cause could not be determined.There were no qns issued during the production of this batch listed in the complaint.All inspections and testing were accepted during the production of this batch.Update.Jun05, 2018.The five (5) samples received will be sent for lab testing.This report will be updated when the lab results are available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD POSIFLUSH¿ HEPARIN LOCK FLUSH SYRINGES
Type of Device
HEPARIN FLUSH
Manufacturer (Section D)
BD MEDICAL (BD WEST) MEDICAL SURGICAL
1852 10th avenue
columbus NE 68601
MDR Report Key7519613
MDR Text Key108456436
Report Number1911916-2018-00229
Device Sequence Number1
Product Code NZW
UDI-Device Identifier30382903064244
UDI-Public30382903064244
Combination Product (y/n)N
PMA/PMN Number
K090680
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Type of Report Initial,Followup,Followup
Report Date 06/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/16/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date05/31/2019
Device Catalogue Number306424
Device Lot Number716087N
Date Manufacturer Received05/01/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-